@AndyT Is there opportunity to listen to the discussion taking place in EMA? I know that HESI/FDA meeting next week will be open to the public virtually.
FDA/HESI Research Roadmap Planning on Hazard and Risk Assessment of Nitrosamine Impurities in Drugs
Day1: Wed, May 31 9:00 AM - 5:00 PM ET
Day2: Thu, Jun 1 8:30 AM - 3:45 PM ET
The goal of the workshop is to engage stakeholders with expertise in the assessment of nitrosamines (NA), including Nitrosamine Drug Substance-related Impurities (NDSRI) in order to achieve the following:
Provide a high-level synthesis of key areas/objectives of current research on NA detection and evaluation;
Identi…